Intercytex
ClosedManchester, United Kingdom · Founded 2000
- Headquarters
- Manchester
- Founded
- 2000
- Business Model
- B2B
- Website
- intercytex.com
About
Intercytex was a Manchester, UK-based regenerative medicine company founded in 2000 that developed cell-based therapy products — including the ICX-SKN skin graft substitute and hair-regeneration treatments — for burns, chronic wounds, and hair loss, running multiple clinical trials in the UK. Facing financial difficulty, the company wound down between 2009 and 2010, selling its stem-cell subsidiary Axordia to Pfizer and other cell-based assets to Healthpoint.
Summary
Intercytex is a Biotech company based in Manchester, United Kingdom, founded in 2000.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/intercytex"><img src="https://indexed.vc/api/badge/company/intercytex" alt="Intercytex on Indexed.vc" width="260" height="76" /></a>